Supplemental Figure 3 from EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1
(A) IF staining of RasB1 and PC3 cells with an antibody for EGFR following EGF and CI1033 treatment. Scale bars represent 50 µm. (B) IHC staining of FFPE cell blocks of RasB1 and PC3 cells with an antibody for p-EGFR (Y1068) following EGF and CI1033 treatment. (C) The intensity of total EGFR was normalized to the internal control, histone 3 or β-actin, from Western blots of nuclear and cytoplasmic cell extracts of RasB1 cells following EGF treatment. (D) The intensity of p-ERK1/2 was normalized to total ERK1/2 from Western blots of nuclear and cytoplasmic cell extracts of RasB1 cells following EGF treatment. (E) ChIP analyses of predicted ATRSs in the pri-miR-1-1 promoter region of 22Rv1 cells following EGF treatment. Enrichment of each protein at each site is given as a percentage of the total input and then normalized to each IgG. Data are presented as the mean {plus minus} SEM, n=3. * vs. -EGF. ** p<0.01, *** p<0.001.